Exclusivity Fees. XXX shall pay to TAI Exclusivity Fees in an aggregate amount of $40,000,000 United States dollars, payable as follows:
Exclusivity Fees. (a) [***] *** Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. [***] indicates that text has been omitted and is the subject of a confidential treatment request. MASTER PRIVATE LABEL FINANCING AGREEMENT
Exclusivity Fees. In consideration for the exclusivity rights granted in Section 2.1 Evelo will pay to Biose an “Exclusivity Fee” of [***] each year during the Term. The first Exclusivity Fee payment will be due within [***] of the Effective Date. The second and third Exclusivity Fee payments will be due within [***] of the first and second anniversaries of the Effective Date, respectively. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Confidential Treatment Requested Evelo Biosciences, Inc.
Exclusivity Fees. (a) [***]
Exclusivity Fees. In consideration of the grant of exclusive rights to Novartis pursuant to Section 2.2:
Exclusivity Fees. (a) In consideration for the exclusive distribution rights granted to Xxxxxx hereunder, Xxxxxx shall make an initial payment to the Company in the amount of $2,000,000 (the “Initial Exclusivity Fee”) in immediately available funds on the tenth (10th) Business Day after the Effective Date. The Company agrees to use the proceeds from the Initial Exclusivity Fee first, to pay expenses associated with the Project and thereafter for general working capital purposes.
Exclusivity Fees. In consideration for the exclusivity rights granted in Section 2.1 Evelo will pay to Biose an “Exclusivity Fee” of two hundred and fifty thousand U.S. dollars ($250,000) each year during the Term. The first Exclusivity Fee payment will be due within [***] of the Effective Date. The second and third Exclusivity Fee payments will be due within [***] of the first and second anniversaries of the Effective Date, respectively. Confidential Portions of this Exhibit marked as [***] have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission. Confidential Treatment Requested Evelo Biosciences, Inc.
Exclusivity Fees. (a) In the event (1) the Buyer terminates this Agreement as a result of a breach by the Seller or the Company or any of their respective Representatives of any obligations under Section 5.3, and (2) Seller consummates an Alternative Transaction with respect to the Company within nine (9) months after such termination of this Agreement, then the Seller will pay to the Buyer (or an Affiliate designated by the Buyer) promptly (but in no event later than five (5) Business Days following consummation of such Alternative Transaction) a cash fee of $4,000,000, payable by wire transfer of immediately available funds to a bank account designated in writing by the Buyer (the “Exclusivity Fee”).
Exclusivity Fees. (1) If the aggregate assets under management in the Product at the end of the first year following the Launch Date for this Schedule I (i.e., on the first anniversary of the actual Launch Date with respect to this Schedule I) are greater than $___ million, then the Exclusivity Period shall remain in effect for a second year following the Launch Date for this Schedule I (i.e., until the second anniversary of the actual Launch Date with respect to this Schedule I) at no additional exclusivity charge to the Licensee.
Exclusivity Fees. 5.2.1 As consideration for FHT’s exclusive efforts in the Exclusive Field, in accordance with Section 2.9, Merck shall make a one-time upfront payment of ten million dollars ($10,000,000.00) no later than thirty (30) days after the Effective Date, and additional ten million dollar ($10,000,000.00) payments on each of the 1st, 2nd, and 3rd anniversaries of the Effective Date.
